Skip to main content
Physio Nexus Academy logo
Physio Nexus Academy
Back to Knowledge Hub
Research & EvidenceSystematic ReviewsClinical LevelStudents

PRISMA 2020: Reporting a Systematic Review Without Hiding the Methods

A practical guide to PRISMA 2020, the flow diagram, transparent reporting and the difference between reporting quality and methodological quality.

3 October 202612 min readEvidence sources included

What You Should Be Able to Explain After Reading

  • Explain what PRISMA 2020 does and does not do.
  • Map a systematic review manuscript to the 27-item checklist.
  • Build a transparent study-selection flow diagram.
  • Avoid confusing reporting guidance with risk-of-bias or certainty assessment.

What PRISMA is

PRISMA 2020 is a reporting guideline for systematic reviews. Its 27-item checklist helps authors report why the review was done, what methods were used, what was found and how results were interpreted. It does not by itself make a review methodologically rigorous.

Before writing

  • State a clear review question and eligibility criteria.
  • Describe all information sources and the full search strategy sufficiently for replication.
  • Report selection, data collection, risk-of-bias and synthesis methods.
  • If a protocol/registration exists, report it and explain important deviations.

Flow diagram reasoning

  • Track records identified, removed before screening, screened, excluded, sought for retrieval, assessed and included.
  • Keep counts internally consistent with screening software and manuscript text.
  • Report reasons for full-text exclusion at the appropriate stage.
  • Do not fabricate a clean flow after the fact; preserve an audit trail during screening.

Results and interpretation

  • Report study characteristics and risk-of-bias results alongside synthesis findings.
  • Present effect estimates and uncertainty where applicable.
  • Discuss heterogeneity, limitations of included evidence and limitations of the review process.
  • Separate certainty-of-evidence judgments from statistical significance.

Common mistakes and clinical pearls

  • PRISMA is not a risk-of-bias tool and is not a substitute for a protocol.
  • A PRISMA flow diagram does not prove that screening was unbiased.
  • Do not cite only the abstract checklist when writing a full review.
  • Clinical pearl: complete the checklist against the final manuscript and record the page/section where each item is reported.

Summary

PRISMA 2020 improves transparency when the checklist and flow diagram accurately reflect the review process; it cannot repair weak methods that were never performed.

Evidence & Further Reading

These sources are provided so learners can trace the clinical recommendations and read the original guidance.